BRETT URIE: Open Payments
NPI 1427875756 · TAVARES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 37 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 7 | $176 |
| Axsome Therapeutics, Inc. | 3 | $166 |
| Novartis Pharmaceuticals Corporation | 6 | $132 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| ABBVIE INC. | 2 | $51 |
| Novo Nordisk Inc | 2 | $44 |
| Exact Sciences Corporation | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Boston Scientific Corporation | 1 | $24 |
Products named: Auvelity, LEQVIO, INGREZZA, TRELEGY ELLIPTA, SHINGRIX, FARXIGA, The Cologuard Plus Collection Kit, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
